Trial Details

COMPLETED
Basic Information
Clinical ID c1395
Identifier NCT05107492
Trial Title Evaluation of the Pharmacokinetics, Safety and Tolerability of Single Dose of PF-06480605 in Chinese Healthy Participants
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Inflammatory Bowel Disease
Interventions DRUG: 450mg|DRUG: 150mg|DRUG: Placebo
Participant Information
Sponsor Pfizer
City Beijing Municipality
Country/Region China
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2021-11-19
Primary Completion Date 2022-04-09
Completion Date 2022-04-09